PKN2 and neoplasm: An analysis of specific CAFs subtypes resulting from PSCs-to-CAFs transformation indicated that both in vivo and in vitro, the absence of PKN2 inhibited PSCs proliferation, reduced αSMA expression, induced a transition from myCAFs to iCAFs and prevented PSCs invasion but promoted tumor growth when cocultured with PDAC tumor cells [111].